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Patients with suspected deep vein thrombosis (DVT) or pul-
monary embolism (PE) are frequently admitted to an
Emergency Department (ED) for initial evaluation. However,
management of patients with suspicion of acute venous
thromboembolism (VTE) in this clinical setting can be diffi-
cult; in fact symptoms and signs of DVT are non-specific and
can be found in a broad spectrum of non-thrombotic disor-
ders. An accurate and timely objective diagnosis is necessary
for immediate and correct identification of patients with
acute VTE, while avoiding the bleeding risk associated with
unnecessary anticoagulant therapy in patients where DVT or
PE have been ruled out. The diagnostic approach to patients
with suspected VTE includes clinical evaluation, diagnostic
imaging and D-dimer testing [1, 2].
In a recent issue of Internal and Emergency Medicine,
Siragusa [3] exhaustively discussed the currently used
assays, clinical indications and limitations of D-dimer testing
for managing acute VTE in emergency medicine.
Measurement of D-dimer values, a degradation product of
cross-linked fibrin, is a simple laboratory test, and has been
extensively studied in numerous prospective cohort studies
in cases of suspected DVT or PE, showing a high negative
predictive value. The author [3] shows that D-dimer testing
has sufficient diagnostic accuracy for ruling out acute VTE if
used in combination with standardised clinical judgement.
The review is important for at least three reasons.
First, many physiological and pathological conditions can
increase plasma D-dimer levels (pregnancy, age, trauma, can-
cer, inflammation and several other clinical conditions); on
the other hand D-dimer levels may fail to increase in patients
with acute VTE for multiple reasons (impaired fibrinolytic
activity, use of heparin or oral anticoagulants, onset of symp-
toms more than two weeks before blood sampling). For these
reasons, D-dimer testing has a high sensitivity but a low
specificity in the diagnosis of acute VTE; in clinical practice
it may be associated with frequent “false positive” results, but
also more rarely with “false negative” findings. However, its
use should always be associated with a careful clinical assess-
ment to rule out the presence of acute VTE only in sympto-
matic patients. Overuse or misuse of the D-dimer screen for
VTE may have negative consequences, in terms of a burden
both for patients and for healthcare costs; in fact, despite clin-
ical guidelines, inappropriate and unnecessary measurement
of D-dimer is a significant clinical problem [4].
Second, commercially available assays are very differ-
ent for many reasons. Assays differ in the type of antibody
used as well as in the type of data provided, as some are
qualitative whereas others are quantitative. Moreover, the
value of various D-dimer assays is based upon several fac-
tors including sensitivity, specificity, cost, time required,
reproducibility and complexity. Finally, the diagnostic
accuracy of D-dimer relies on the cut-off values, that is the
range within which the test has the best sensitivity and
specificity, and may be very different comparing one assay
to another. Cut-off points are established by the manufac-
turers, according to the characteristics of D-dimer testing;
a wide range of sensitivities and specificities have been
reported for different D-dimer assays. Currently, no D-
dimer reference standard exists, making interassay corre-
lation poor; moreover, because of variations and differ-
ences among different assays, results from one of them
cannot be extrapolated to another.
Third, another interesting issue concerning the use of
the D-dimer test in emergency medicine is its use when
urgent diagnostic imaging for DVT or PE is not immedi-
ately available, as for example during a night-time or
week-end evaluation. Siragusa and coworkers [5] studied
whether a combined approach consisting of pre-test clini-
cal probability, D-dimer testing and low-molecular-weight
heparin (LMWH) allowed deferral of objective assessment
of DVT or PE for up to 72 h in 409 patients admitted to ED
for suspected VTE. Pending diagnostic confirmation,
patients identified with a high probability or with a mod-
erate probability and positive D-dimer test received a pro-
tective full dose of LMWH, while the remaining patients
were discharged without anticoagulant treatment. The
study demonstrates the safety of this approach.
Despite the promise of these findings, there are sever-
al points of caution worth noting with respect to the use71
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of the D-dimer test in the ED. Researchers remain con-
cerned that qualitative D-dimer assays may demonstrate
lower diagnostic sensitivity compared with quantitative D-
dimer assays, which are becoming more widely used in EDs
to rule out the diagnosis of PE. Recently two important stud-
ies clearly demonstrated that a simplified D-dimer assay has
a moderate sensitivity for PE in patients with clinical pre-
test low-risk probability [6] or is not sufficiently sensitive to
exclude the diagnosis of PE in all symptomatic patients pre-
senting to the ED with pleuritic chest pain [7]. In addition,
as is reported by Squizzato and Ageno [8], physicians work-
ing in the ED should be adequately educated about the opti-
mal use of D-dimer testing in diagnosing acute VTE. In fact,
inappropriate use of D-dimer testing is a common error, and
may cause several clinical problems; for example, given the
high likelihood of false positive results, the costly and time-
consuming need for unnecessary additional imaging tests.
Thus, it is mandatory that clinicians be aware of the poten-
tial limitations of D-dimer testing. It is clear for example
that D-dimer testing has sufficient diagnostic accuracy for
ruling out acute VTE only if it is used in combination with
a standardised clinical probability score judgement, but
not when used alone.
In conclusion, as Siragusa et al. report, I believe that D-
dimer testing can be safely used in ED for ruling out acute
VTE only if used in combination with a correct and validat-
ed pre-test clinical probability [5]. The reliance upon a D-
dimer test seems to be a safe and reliable practice in the man-
agement of patients with suspicion of VTE when appropriate
imaging tests are not immediately available. Moreover,
because of its heterogeneity related to the method used, a D-
dimer test accuracy should be carefully assessed in each hos-
pital before its implementation in the emergency diagnosis of
VTE. Finally, emergency physicians should receive adequate
education concerning the correct use and limitations of a D-
dimer test, to avoid error in its use in clinical practice.
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